SPYRE THERAPEUTICS, INC. Finance Lease, Liability, Undiscounted Excess Amount
SPYRE THERAPEUTICS, INC. (SYRE) had Finance Lease, Liability, Undiscounted Excess Amount of $6.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-08.
Discontinued › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2022-03-08
- 2021-12-31: Finance Lease, Liability, Undiscounted Excess Amount $6.00K.
- 2020-12-31: Finance Lease, Liability, Undiscounted Excess Amount $9.00K.
- 2019-12-31: Finance Lease, Liability, Undiscounted Excess Amount $5.00K.
- 2019-09-30: Finance Lease, Liability, Undiscounted Excess Amount $7.00K.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2021-12-31 | $6.00K 10-K · filed 2022-03-08 |
| 2020-12-31 | $9.00K 10-K · filed 2021-03-18 |
| 2019-12-31 | $5.00K 10-K · filed 2020-02-24 |
| 2019-09-30 | $7.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $9.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $10.00K 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |